HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 74 filers reported holding HARVARD BIOSCIENCE INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $856,000 | -57.8% | 335,656 | -57.0% | 0.03% | -59.5% |
| Q1 2017 | $2,028,000 | -21.8% | 780,020 | -8.3% | 0.07% | -23.7% |
| Q4 2016 | $2,595,000 | +11.9% | 850,763 | -0.3% | 0.10% | +10.2% |
| Q3 2016 | $2,320,000 | -7.2% | 852,901 | -2.4% | 0.09% | -8.3% |
| Q2 2016 | $2,500,000 | -7.7% | 874,248 | -2.6% | 0.10% | -6.8% |
| Q1 2016 | $2,710,000 | -13.8% | 897,283 | -1.0% | 0.10% | -10.4% |
| Q4 2015 | $3,144,000 | -8.2% | 905,982 | 0.0% | 0.12% | -14.2% |
| Q3 2015 | $3,425,000 | -63.8% | 905,982 | -45.4% | 0.13% | -21.2% |
| Q2 2015 | $9,458,000 | +84.7% | 1,659,430 | +88.5% | 0.17% | -4.5% |
| Q1 2015 | $5,122,000 | -99.9% | 880,119 | -16.2% | 0.18% | -7.8% |
| Q4 2014 | $5,958,144,000 | +145008.2% | 1,050,819 | +4.7% | 0.19% | +40.9% |
| Q3 2014 | $4,106,000 | -99.9% | 1,003,819 | +1.3% | 0.14% | -4.2% |
| Q2 2014 | $4,509,136,000 | +252512.7% | 991,019 | +163.1% | 0.14% | +150.9% |
| Q1 2014 | $1,785,000 | – | 376,619 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AMH Equity Ltd | 2,000,000 | $10,980,000 | 12.55% |
| 272 Capital LP | 3,062,963 | $16,815,667 | 6.18% |
| Meros Investment Management, LP | 813,014 | $4,463,447 | 2.21% |
| Harvey Partners, LLC | 2,524,000 | $13,856,760 | 1.70% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 2,862,649 | $15,715,943 | 0.96% |
| BARD ASSOCIATES INC | 286,922 | $1,575,202 | 0.61% |
| Acuitas Investments, LLC | 180,300 | $989,847 | 0.58% |
| Portolan Capital Management | 783,591 | $4,301,915 | 0.38% |
| Archon Capital Management LLC | 279,358 | $1,533,675 | 0.32% |
| HEARTLAND ADVISORS INC | 850,000 | $4,666,500 | 0.27% |